* Prothena Corporation PLC PRTA.OQ PRTA.O is expected
to show
a fall in quarterly revenue when it reports results on November
3.
* The Dublin Ireland; Republic of-based company is
expected to
report a 84.1% decrease in revenue to $22.063 million from
$139.17 million a year ago, according to the mean estimate from
8 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prothena
Corporation PLC
is for a loss of 53 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prothena
Corporation PLC is $75, above its last closing price
of $59.70.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.58 -0.52 -0.88 Missed -68.1
Mar. 31 2022 -0.75 -0.68 -0.78 Missed -15.3
Dec. 31 2021 -0.59 -0.58 -0.71 Missed -21.6
Sep. 30 2021 2.28 2.28 2.13 Missed -6.5
Jun. 1.69 1.00 0.58 Missed -41.9
30 2021
Mar. 31 2021 -0.69 -0.54 -0.91 Missed -67.9
Dec. 31 2020 -0.81 -0.77 -0.77 Met -0.1
Sep. 30 2020 -0.67 -0.65 -0.77 Missed -18.1
This summary was machine generated October 28 at 18:40 GMT. All
figures in US dollars unless otherwise stated